To test whether AT2‑derived lipids are required for metastasis, the researchers selectively deleted Fasn in AT2 cells.

The model has the potential to transform the ability to study telomere biology, learn more about human aging, and ultimately help people preserve better health as they age.

A new strategy strengthens the bond between the T cell and a target tumor cell, improving the cytotoxic function of the T cell.

Liège-based Bio‑Sourcing and Roanoke-based The Tiny Cargo Company inked a strategic collaboration to co‑develop orally delivered monoclonal antibody (mAb)-based therapies formulated using goat ...

Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to schizophrenia.

Nautilus debuted its platform at the US HUPO meeting last month and is seeking additional participants for its ongoing early access program.

The researchers say that, to their knowledge, this is the first demonstration of programmable, site-specific integration of a large DNA payload into T cells in vivo.

MilliporeSigma, the U.S. and Canadian Life sciences business of Merck KGaA, Darmstadt, Germany, has set out to establish a leading presence in organoid development, starting with its €104 million ...

Cayman advanced the protocol from a 1-L setup to a 100-L pilot run, operating the reaction and analysis independently.

Roche’s AI factories, protein design reasoning model, and healthcare robotics are among GTC announcements for biology.

Astellas Pharma has ended a six-year-old collaboration with CytomX Therapeutics designed to both expand the pharma giant’s pipeline of next-gen immuno-oncology treatments and generate up to $1.68 ...

Construction is already underway at Axplora's Farmabios HPAPI manufacuring facility in Italy, with completion targeted for February 2027.